
Chief Executive Officer @rxsight Med Tech/ Biotech Executive (all opinions expressed are my own)
Orange County, CA
Joined April 2009
- Tweets171
- Following496
- Followers345
- Likes2.1K
Aziz Mottiwala retweeted
We are pleased to share our Q3 2023 financial results, along with updates on key business milestones. Learn more: bit.ly/3Sy9W5E
Tarsus Update
Aziz Mottiwala retweeted
The first and only FDA-approved treatment for Demodex blepharitis is now available! This new treatment has the potential to change the way this highly prevalent disease is treated. Thanks to our team and partners who helped make this milestone possible.
Read the announcement.
Aziz Mottiwala retweeted
We’re feeling inspired after an incredibly productive #ASCRS2023 in sunny San Diego! We enjoyed collaborating with and learning from experts, peers and colleagues to discuss innovation in #eyecare and how to meaningfully impact patient care.
@ASCRStweets
Aziz Mottiwala retweeted
The Tarsus team had a productive and fun @VisionExpo East 2023 in the Big Apple, spending quality time with eye care professionals and discussing how to serve patients with unmet needs.
#VisionExpo
Aziz Mottiwala retweeted
A very productive #SECO100, including a presentation by CCO @AzizMottiwala at @OISTWEETS’s OIS@SECO event and many engaging discussions with #eyecare professionals about serving patients with unmet needs!
Aziz Mottiwala retweeted
Our Chief Commercial Officer @AzizMottiwala will be sharing more about our 2023 plans to serve the unmet needs of #eyecare patients during the “Spotlight on Ocular Surface Disease” session at OIS @ SECO next week in Atlanta. Hope to see you there!
#ois #oisseco #seco
@OISTWEETS
Aziz Mottiwala retweeted
As 2022 comes to a close, we once again take a moment to reflect on our accomplishments over the past year. We are extremely grateful to all of our Tarsans, who continue to foster a culture dedicated to serving our patients. Looking forward to all the upcoming milestones in 2023!
Aziz Mottiwala retweeted
We are pleased to announce positive topline results from the Phase 1b Callisto trial and the enrollment of the first subject in the Carpo Phase 2a trial to evaluate TP-05 for the potential prevention of Lyme disease. Read more in the full press release.
Aziz Mottiwala retweeted
Demodex blepharitis is hiding in plain sight—know where to look! If I see collarettes at the base of the lash while my patient looks down during an exam, I’m dealing with DB. Visit lookatthelids.com @lookatthelids! #LookattheLids #Demodex #PaidforbyTarsus #SponsoredbyTarsus
Aziz Mottiwala retweeted
Meet 𝘋𝘦𝘮𝘰𝘥𝘦𝘹! The easiest way to diagnose 𝘋𝘦𝘮𝘰𝘥𝘦𝘹 blepharitis is to look for collarettes at the base of the eyelash. Ask pts to look⬇️ during eye exams! Visit lookatthelids.com +follow @lookatthelids! #LookattheLids #Demodex #PaidforbyTarsus #SponsoredbyTarsus
Aziz Mottiwala retweeted
Our team had a great time this weekend at the @AAO_Ophth Annual Meeting! We loved connecting with industry leaders and eye care professionals at “Changing the Game in Eye Care”. Thanks to all who stopped by our booth - we’re already counting down to next year! #AAO2022
Aziz Mottiwala retweeted
It’s almost time! Join our team at Soldier Field this Friday, 9/30, at 4:30 PM CT to see experts in ophthalmology face off in the Folliculorum Feud, a ferocious fight between 2 factions, fueled by #Demodex facts and fervor!
Aziz Mottiwala retweeted
Attending the INCLUSION: Diversity, Equity and Inclusion Summit next week as a part of @BiotechWkBoston? Check out our Chief Human Resources Officer Dianne Whitfield's panel discussing building future talent structures that inspire inclusion and cultivate a winning culture!
Aziz Mottiwala retweeted
An exciting milestone for our Tarsans! We are proud to announce that we have submitted an NDA to the FDA for our lead investigational treatment for Demodex blepharitis. Thank you to everyone who has helped us achieve this important milestone, we couldn't have done it without you!
Very excited to share the first and only educational campaign dedicated to raising eye care professional awareness of Demodex blepharitis, a highly prevalent eyelid margin disease affecting ~25 million eye care patients in the U.S.
Lookatthelids.com
Aziz Mottiwala retweeted
Our Tarsans just donated 50 backpacks full of school supplies to support @CAPOrangeCounty with their Backpacks for Success volunteer event. Proud to support kids in the local community as they get ready to go back to school this fall!
Aziz Mottiwala retweeted
Hear from @azamian, @lizyeu, and @AzizMottiwala tomorrow at the @OctaneOC Ophthalmology Tech Summit. We are excited to share more about our innovative approach to revolutionizing treatment for patients with Demodex blepharitis. #OctaneOC
Aziz Mottiwala retweeted
Did you know up to 25 million Americans may have Demodex blepharitis? Dr. Gregg Berdy discusses the widespread prevalence of this disease that the Titan study showed is responsible for over two thirds of blepharitis cases. #demodex #blepharitis
Aziz Mottiwala retweeted
Bobak Azamian, MD, PhD, (@azamian) CEO and co-founder of @TarsusRx, discusses topline data from the Saturn-2 phase 3 study of TP-03 for the treatment of Demodex blepharitis.
healio.com/news/ophthalmolog…
#blepharitis #mednews














